Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults

Name: Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults
License: Public Domain

Valneva Austria GmbH

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

zika, zika virus infection

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 321559
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.